SCHEMBL29922602

SCHEMBL29922602

COC(=O)c1nnc(Cl)cc1Nc1ccc(C(=O)OC(C)(C)C)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SYK P43405 1/20 0.43
▸ STAT3 P40763 2/20 0.42
▸ ABCG2 Q9UNQ0 1/20 0.42
▸ KDM4E B2RXH2 3/20 0.41
▸ KMT2A Q03164 6/20 0.41
▸ MAPT P10636 2/20 0.41
▸ MITF O75030 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ MEN1 O00255 3/20 0.40
▸ HPGD P15428 1/20 0.40
▸ RXFP1 Q9HBX9 1/20 0.40
▸ CDC25A P30304 1/20 0.40
▸ CDC25B P30305 1/20 0.40
▸ SIRT2 Q8IXJ6 1/20 0.39
▸ BTK Q06187 1/20 0.39
▸ GAA P10253 1/20 0.38
▸ CNR1 P21554 1/20 0.38
▸ CA12 O43570 1/20 0.38
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28362546 1.00 SYK (0.43) SYKSTAT3ABCG2KDM4EKMT2A
SCHEMBL28362756 0.87 ABCB1 (0.45) SYKABCG2KDM4EKMT2AMAPT
SCHEMBL29551921 0.87 ABCB1 (0.45) SYKABCG2KDM4EKMT2AMAPT
SCHEMBL29922810 0.87 ABCB1 (0.45) SYKABCG2KDM4EKMT2AMAPT
SCHEMBL28359014 0.85 SYK (0.41) SYKKDM4EKMT2AMAPTMITF
SCHEMBL29551791 0.85 SYK (0.41) SYKKDM4EKMT2AMAPTMITF
SCHEMBL28359228 0.84 SYK (0.40) SYKKMT2AMAPTCNR1LMNA
SCHEMBL29922815 0.84 SYK (0.40) SYKKMT2AMAPTMEN1LMNA
SCHEMBL29922807 0.84 SYK (0.40) SYKKMT2AMAPTCNR1LMNA
SCHEMBL28359212 0.84 SYK (0.40) SYKKMT2AMAPTMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110818641-B Pyridazine-3-formamide compound, preparation method and application thereof in medicine and pharmacology 北京诺诚健华医药科技有限公司 2022-10-14 — — CN disclosed
Send feedback